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Abstract
Classical molecular dynamics (MD) simulations will be able to reach sam-
pling in the second timescale within five years, producing petabytes of simula-
tion data at current force field accuracy. Notwithstanding this, MD will still
be in the regime of low-throughput, high-latency predictions with average
accuracy. We envisage that machine learning (ML) will be able to solve both
the accuracy and time-to-prediction problem by learning predictive models
using expensive simulation data. The synergies between classical, quantum
simulations and ML methods, such as artificial neural networks, have the po-
tential to drastically reshape the way we make predictions in computational
structural biology and drug discovery.
Highlights
• Classical MD will reach the second timescale and generate petabytes
of data within five years.
• Accuracy and cost will still restrict simulations to approximate results
and high-latency predictions.
• Machine learning has the potential to deliver more accurate and faster
predictions by learning predictive models from expensive simulations.
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Signs of this paradigm change are already present today in quantum
calculations.
Introduction
Molecular dynamics (MD) simulations are one of the predominant tech-
niques to study protein dynamics. MD is often used to capture dynamical
processes of proteins across different timescales with atomistic details in or-
der to rationalize biological phenomena. Despite the potential to become a
surrogate model of real protein dynamics, some important issues still remain
to be solved, mainly: i) high computational cost and sampling limitations [1]
and ii) force field accuracy [2, 3, 4].
Classical MD simulations constitute a balance between accuracy and effi-
ciency. For example, quantum-level phenomena such as enzymatic reactions,
polarizability and proton transfers are neglected in exchange for computa-
tional speed. Commonly used force fields, based on a parameterization of a
closed form potential, are fast to compute, but use approximations that for-
feit accuracy. The extent to which these limitations may affect the validity
of the results depends on the system and the biological question at hand.
Quantum mechanics (QM) calculations can be used to obtain an accurate
description of a molecule, but are computationally demanding and very lim-
ited in terms of sampling. Ideally, one would like to simulate at quantum
level accuracy, which describes the physics and chemistry precisely, but at
the sampling regime of current classical simulations.
The first simulation of protein dynamics dates from 1977 and consisted
of a 9.2 ps trajectory of the bovine pancreatic trypsin inhibitor (BPTI) in
vacuum [5]. In 2010, [6] reported a 1 millisecond trajectory of the same
protein in explicit solvent, which constitutes a 100 million increase in trajec-
tory length compared to the first simulation. In 30 years, MD simulations
have increased sampling capabilities over 8 orders of magnitude, with in-
creasing accuracy in the force fields [2, 3, 4]. In the last 10 years, MD has
evolved from single simulation [7, 8, 9] to high-throughput molecular dy-
namics studies [10, 11, 12, 13, 14, 15, 16], where hundreds of microseconds
of simulations are computed in independent trajectories to obtain converged
statistics. Software and hardware innovations, such as the implementation
of MD codes for GPUs [17, 18, 19, 20], distributed computing projects like
Folding@home [21], GPUGRID [22] and the development of special-purpose
supercomputers like ANTON [23], are steadily decreasing the computational
2
cost of molecular simulations. Additionally, the development of adaptive
sampling schemes have introduced more efficient ways to sample conforma-
tional space, decreasing the amount of simulations needed [24, 25, 26].
In a recent review we estimated that MD would reach seconds of aggre-
gated sampling using commodity hardware by 2022 [27] [Fig 1a], generating
petabytes of simulation data. For instance, the file size of one second of
simulation data of a 60,000-atom system (e.g. a GPCR system) at 0.1 ns
per frame is 7.2 Petabytes (reduced to a third using compressed trajectory
file formats). This amount of data constitutes a valuable source of infor-
mation, but the knowledge extracted from it is mainly used to rationalize a
particular protein system at hand, not to generalize it to other systems. In
this review, we envision a paradigm change in the near future where expen-
sive simulations (QM and MD) are not used to predict but to learn models,
so that further predictions can be drawn using ML approaches. By doing
so, the large computational cost required by simulations becomes justifiable,
in particular if the results are more accurate by the use of more expensive
simulation methods.
Machine learning applied to structural biology
ML approaches are not new in simulation analysis. For instance, the com-
mon analysis pipeline for MD simulations involves dimensionality reduction
[28, 29, 30, 31, 32, 33]) and clustering algorithms.
In the last few years, ML applications have grown exponentially. One of
the main factors driving this growth is the broad popularization of a par-
ticular type of ML called deep neural networks [34, 35]. An artificial neural
network (NN) is a simple mathematical framework organized in layers, each
of them performing a matrix multiplication and a non-linear function of the
input variables x. The output of a single neuron φ in each layer is given by
φ = f(wtx + b), where w are learnable weights, b is a bias and f is some
nonlinear function. NNs can have several to hundred of nested layers and in
such cases is called ”deep”. Given enough parameters, a NN is capable of
interpolating any continuous function [36, 37].
The application of NN models in computational biology is steadily in-
creasing [38]. For instance, the Merck molecular activity challenge demon-
strated the potential of deep neural network models in drug discovery [39].
DeepTox [40] is a deep learning-based model for toxicity prediction of com-
pounds, winning the Tox21 toxicology prediction challenge in 2014 by a large
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margin. Variational autoencoders [41], a generative flavor of deep NNs, were
recently applied to convert discrete representations of molecules to and from a
multidimensional continuous representation [42], allowing for efficient search
and optimization through open-ended spaces of chemical compounds. Ad-
ditionally, autoencoders have also been used for dimensionality reduction in
MD [43, 44, 45]. VAMPnets [46] fit a Markov state model from the system
specific molecular simulation data. NNs have also been used to reproduce
the free-energy surface of molecules [47]. Deep convolutional neural networks
(CNN) [48] have become increasingly popular due to its performance in ma-
chine vision, a property that has been exploited by us and others to apply
it on structural biology by treating proteins as 3D images. CNNs have been
used for ligand binding site detection [49], ligand pose prediction [50], ligand
active/inactive classification [51], ligand binding affinity prediction [52] and
protein design [53]. Also, the DeepChem software [54] and the MoleculeNet
challenge [55] provide multiple featurization algorithms and access to relevant
QSAR prediction datasets.
Case 1: ML models to predict quantum forces using QM simulation
data
One important application case of ML is apparent in quantum mechanics.
QM simulations are notoriously computationally expensive and, depending
on the level of theory, scales poorly with the number of atoms of the system
[59]. It is therefore not surprising that there have been efforts to interpolate
the QM many-body potential with NNs to obtain a predictive model of QM
forces.
Many studies on approximating QM with NNs were performed previously
to the recent NN resurgence. In particular, Behler et al. [60, 61, 62] con-
tributed significantly to the field for small molecules and on ways to fit quan-
tum observables, e.g. infrared spectra [63]. The initial effort went to provide
usable symmetry functions that could guarantee basic physical principles like
translational, rotational [64] and invariance on atom reordering to the learned
potentials. Transferability, however, was limited until recently[65].
In [65, 66, 67, 68], NNs are trained from QM simulation data to generate
the potential energy surface and forces for small molecules, generalizing to
unseen molecules, including some preliminary tests on proteins. In the same
way as MD force fields do, forces are true derivatives of the interpolated
potential energy surface using the gradients of the NN, and can be used to
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Figure 1: Overview of a combined simulation and machine learning approach. a. MD
data generation is expected to reach the second aggregated timescale by 2022 and an
output files size of several petabytes by 2022 based on a trend of maximum aggregated
time per paper per year using the ACEMD software. Chart adapted from [27]. Referenced
publications correspond to [12, 13, 15, 29, 56, 57, 58]. b. A first example of ML replacing
QM to predict dihedral energies given a neural network trained with QM simulations. c.
An example of data augmentation by MD: augment protein-ligand binding poses for a set
of protein-ligand pairs with unknown binding mode; augment binding affinity data for a
set of resolved protein-ligand complex structures of unknown affinities.
run dynamics. This guarantees that the forces produced by the NNs yields
a conservative field [69]. The QM energy potential is therefore learned with
the accuracy of first-principle based methods, using generated datasets for
many molecules. The computational cost of generating the datasets is of
course very large, but once trained, the NN inference cost is many orders
of magnitude faster than the QM computational model and comparable in
costs to standard classical MD [Fig 1b].
Case 2: ML models to predict binding affinities using MD simula-
tion data
MD software for GPU has made simulations of full protein-ligand bind-
ing processes possible, allowing the prediction of thermodynamic and kinetic
properties [12, 13]. At the moment, a trade-off between accuracy and sam-
pling restricts the applicability of MD compared to other commonly used
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methods used in drug design, like docking, less accurate but significantly
faster. Even if the sampling problem is solved via brute force, MD does
not currently guarantee that the results are correct because of the approx-
imations of the force fields. The last point can be mitigated by the use of
QM/ML force fields in the future.
Recently, we explored the use of machine vision NN models for binding
affinity prediction. In KDEEP [52], a ML model is used to predict bind-
ing affinities, which consists of a CNN trained on the PDBBind database
[70]. The method shows an overall good mean correlation (0.82) when tested
against the PDBBind’s core set. This set contains several targets clustered
by sequence similarity, in order to define a representative, non-redundant
subset of proteins. For few of these protein clusters, however, the correlation
disappears or even becomes negative. This fact might be explained by a
lack of training data for specific protein pockets, which ultimately leads to a
poor generalization in these cases. KDEEP is structure-based, i.e. it requires
labelled data in the form of the structure of the protein-ligand complex and
their affinity. One way to address this issue would be to extend the avail-
able training datasets by obtaining new affinity data or structures, either
experimentally or computationally (Fig. 1c). Experiments are of course a
possibility, viable for pharmaceutical companies and some academic groups.
Here we prefer to look at the computational options which can be more au-
tomated in active learning methods and are subjected to be exponentially
cheaper in the future.
A potential synergy between MD and ML would improve the accuracy
of predictive NN models, delivering predictions several orders of magnitude
faster than simulations. This level of performance is needed for large pre-
diction studies in drug design, where thousands of molecules need to be
evaluated, such as in virtual screening. As for training KDEEP, the two most
popular binding affinity databases are PDBBind [70] and Binding MOAD
[71]. PDBind’s latest release (v2017) screened the 124,962 structures in the
PDB database [72] (as in Jan 1st, 2017) and identified 59,805 valid molecular
complex structures into four main categories: protein-small ligand, nucleic
acid-small ligand, protein-nucleic acid and protein-protein complexes. From
this set of structures, they defined the general set, providing binding affinity
data (KD/KI and IC50) for a total of 17,900 biomolecular complexes in the
PDB database, including protein-ligand (14,761), nucleic acid-ligand (121),
protein-nucleic acid (837), and protein-protein complexes (2,181). The other
dataset, Binding MOAD, contains binding information for 9142 structures,
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being 6862 of them overlapped with PDBBind. This makes a total of 20,065
co-crystal structures with binding data, out of the 59,805 complex structures
detected in the PDB. A naive example of synergy could be to increase the
available affinity data for the remaining 39,740 structures by simulations.
This, however would be very expensive and arguably impractical in a pre-
diction study. Yet in the context of generating a database for training NN
models, it only needs to be performed once, and possibly at very high ac-
curacy using QM/ML-based force fields to obtain very accurate data. The
resulting NN will be used for predictions. Another possible example comes
from the BindingDB dataset [73] which contains about 1,419,347 binding
data for 7,000 proteins and over 635,301 drug-like molecules, but for most of
the protein-ligand pairs there is no co-crystal structural information. To fill
up this gap, simulations could be used to predict ligand binding poses. As
a rough estimation, if approximately 10µs are needed to obtain the ligand
binding pose for a pair of protein-ligand using adaptive sampling methods[26],
with 1s of aggregate time one could generate 100,000 new predicted protein-
ligand structures over the course of one year[27]. This augmented dataset
build at high computational and time cost is then used for learning fast
predictive models, e.g. KDEEP.
Discussion
In this article we illustrate how generated data produced by simulations
might be used to develop new and better predictive ML models. Generation
of datasets is not hampered by fast return times, which means that better
simulation methods can be used, while ML is used to obtain fast predictions.
One existing example of this approach are QM simulations of biomolecules,
used to generate data for learning a NN QM potential, a paradigm that could
improve on classical force fields in the near future. A further possible exam-
ple, build upon the experience obtained in KDEEP, is where simulations are
used as a data augmentation tool, delegating the binding affinity prediction
to ML-based methods.
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